{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:30:00Z","timestamp":1783189800908,"version":"3.54.6"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Allgrove disease is a rare genetic syndrome characterized by adrenal insufficiency, alacrimia, achalasia and complex neurological involvement. Allgrove disease is due to recessive mutations in the\n                      <jats:italic>AAAS<\/jats:italic>\n                      gene, which encodes for the nucleoporin Aladin, implicated in the nucleocytoplasmic transport. The adrenal insufficiency has been suggested to rely on adrenal gland-ACTH resistance. However, the link between the molecular pathology affecting the nucleoporin Aladin and the glucocorticoid deficiency is still unknown.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>By analyzing postmortem patient\u2019s adrenal gland, we identified a downregulation of Aladin transcript and protein. We found a downregulation of Scavenger receptor class B-1 (SCARB1), a key component of the steroidogenic pathway, and SCARB1 regulatory miRNAs (mir125a, mir455) in patient\u2019s tissues. With the hypothesis of an impairment in the nucleocytoplasmic transport of the SCARB1 transcription enhancer cyclic AMP-dependent protein kinase (PKA), we detected a reduction of nuclear Phospho-PKA and a cytoplasmic mislocalization in patient\u2019s samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results shed a light on the possible mechanisms linking ACTH resistance, SCARB1 impairment, and defective nucleocytoplasmic transport.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-023-02763-w","type":"journal-article","created":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T23:09:32Z","timestamp":1687129772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["SCARB1 downregulation in adrenal insufficiency with Allgrove syndrome"],"prefix":"10.1186","volume":"18","author":[{"given":"Giacomo","family":"Bitetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Ronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pittaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Melzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Peverelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvia Milena","family":"Cribi\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo P.","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6478-026X","authenticated-orcid":false,"given":"Alessio","family":"Di Fonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"key":"2763_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00042","author":"W-J Shen","year":"2016","unstructured":"Shen W-J, Azhar S, Kraemer FB. ACTH regulation of adrenal SR-B1. Front Endocrinol. 2016. https:\/\/doi.org\/10.3389\/fendo.2016.00042.","journal-title":"Front Endocrinol"},{"key":"2763_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/er.2010-0013","volume":"32","author":"WL Miller","year":"2011","unstructured":"Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011;32:81\u2013151. https:\/\/doi.org\/10.1210\/er.2010-0013.","journal-title":"Endocr Rev"},{"key":"2763_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0303-7207(02)00363-5","volume":"198","author":"WL Miller","year":"2002","unstructured":"Miller WL. Androgen biosynthesis from cholesterol to DHEA. Mol Cell Endocrinol. 2002;198:7\u201314. https:\/\/doi.org\/10.1016\/S0303-7207(02)00363-5.","journal-title":"Mol Cell Endocrinol"},{"key":"2763_CR4","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/NEJM198511213132106","volume":"313","author":"JH Laragh","year":"1985","unstructured":"Laragh JH. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med. 1985;313:1330\u201340. https:\/\/doi.org\/10.1056\/NEJM198511213132106.","journal-title":"N Engl J Med"},{"key":"2763_CR5","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1056\/NEJM196510072731506","volume":"273","author":"R Hilf","year":"1965","unstructured":"Hilf R. The mechanism of action of ACTH. N Engl J Med. 1965;273:798\u2013811. https:\/\/doi.org\/10.1056\/NEJM196510072731506.","journal-title":"N Engl J Med"},{"key":"2763_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/ncpendmet0165","volume":"2","author":"AJL Clark","year":"2006","unstructured":"Clark AJL, Metherell LA. Mechanisms of disease: the adrenocorticotropin receptor and disease. Nat Clin Pract Endocrinol Metab. 2006;2:282\u201390. https:\/\/doi.org\/10.1038\/ncpendmet0165.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2763_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00024","author":"C Ruggiero","year":"2016","unstructured":"Ruggiero C, Lalli E. Impact of ACTH signaling on transcriptional regulation of steroidogenic genes. Front Endocrinol (Lausanne). 2016. https:\/\/doi.org\/10.3389\/fendo.2016.00024.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2763_CR8","doi-asserted-by":"publisher","first-page":"33545","DOI":"10.1074\/jbc.271.52.33545","volume":"271","author":"A Rigotti","year":"1996","unstructured":"Rigotti A, Edelman ER, Seifert P, Iqbal SN, DeMattos RB, Temel RE, et al. Regulation by adrenocorticotropic hormone of the in vivo expression of scavenger receptor class B type I (SR-BI), a high density lipoprotein receptor, in steroidogenic cells of the murine adrenal gland. J Biol Chem. 1996;271:33545\u20139. https:\/\/doi.org\/10.1074\/jbc.271.52.33545.","journal-title":"J Biol Chem"},{"key":"2763_CR9","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1128\/MCB.01002-12","volume":"32","author":"Z Hu","year":"2012","unstructured":"Hu Z, Shen W-J, Kraemer FB, Azhar S. MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells. Mol Cell Biol. 2012;32:5035\u201345. https:\/\/doi.org\/10.1128\/MCB.01002-12.","journal-title":"Mol Cell Biol"},{"key":"2763_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.tem.2005.10.006","volume":"16","author":"AJL Clark","year":"2005","unstructured":"Clark AJL, Metherell LA, Cheetham ME, Huebner A. Inherited ACTH insensitivity illuminates the mechanisms of ACTH action. Trends Endocrinol Metab. 2005;16:451\u20137. https:\/\/doi.org\/10.1016\/j.tem.2005.10.006.","journal-title":"Trends Endocrinol Metab"},{"key":"2763_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1365-2265.2009.03663.x","volume":"72","author":"TTLL Chung","year":"2010","unstructured":"Chung TTLL, Chan LF, Metherell LA, Clark AJL. Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2. Clin Endocrinol (Oxf). 2010;72:589\u201394. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03663.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2763_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ng1501","volume":"37","author":"LA Metherell","year":"2005","unstructured":"Metherell LA, Chapple JP, Cooray S, David A, Becker C, R\u00fcschendorf F, et al. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat Genet. 2005;37:166\u201370. https:\/\/doi.org\/10.1038\/ng1501.","journal-title":"Nat Genet"},{"key":"2763_CR13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/81642","volume":"26","author":"A Tullio-Pelet","year":"2000","unstructured":"Tullio-Pelet A, Salomon R, Hadj-Rabia S, Mugnier C, de Laet M-H, Chaouachi B, et al. Mutant WD-repeat protein in triple-A syndrome. Nat Genet. 2000;26:332\u20135. https:\/\/doi.org\/10.1038\/81642.","journal-title":"Nat Genet"},{"key":"2763_CR14","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/S0140-6736(78)91268-0","volume":"1","author":"J Allgrove","year":"1978","unstructured":"Allgrove J, Clayden GS, Grant DB, Macaulay JC. Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet. 1978;1:1284\u20136.","journal-title":"Lancet"},{"key":"2763_CR15","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1530\/EC-17-0255","volume":"6","author":"H Patt","year":"2017","unstructured":"Patt H, Koehler K, Lodha S, Jadhav S, Yerawar C, Huebner A, et al. Phenotype\u2013genotype spectrum of AAA syndrome from Western India and systematic review of literature. Endocr Connect. 2017;6:901\u201313. https:\/\/doi.org\/10.1530\/EC-17-0255.","journal-title":"Endocr Connect"},{"key":"2763_CR16","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1083\/jcb.200206106","volume":"158","author":"JM Cronshaw","year":"2002","unstructured":"Cronshaw JM, Krutchinsky AN, Zhang W, Chait BT, Matunis MJ. Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol. 2002;158:915\u201327. https:\/\/doi.org\/10.1083\/jcb.200206106.","journal-title":"J Cell Biol"},{"key":"2763_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nature06405","volume":"450","author":"F Alber","year":"2007","unstructured":"Alber F, Dokudovskaya S, Veenhoff LM, Zhang W, Kipper J, Devos D, et al. The molecular architecture of the nuclear pore complex. Nature. 2007;450:695\u2013701. https:\/\/doi.org\/10.1038\/nature06405.","journal-title":"Nature"},{"key":"2763_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/hmg\/10.3.283","volume":"10","author":"K Handschug","year":"2001","unstructured":"Handschug K. Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet. 2001;10:283\u201390. https:\/\/doi.org\/10.1093\/hmg\/10.3.283.","journal-title":"Hum Mol Genet"},{"key":"2763_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuroscience.2004.10.029","volume":"131","author":"HL Storr","year":"2005","unstructured":"Storr HL, Clark AJL, Priestley JV, Michael GJ. Identification of the sites of expression of triple a syndrome mRNA in the rat using in situ hybridisation. Neuroscience. 2005;131:113\u201323. https:\/\/doi.org\/10.1016\/j.neuroscience.2004.10.029.","journal-title":"Neuroscience"},{"key":"2763_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-020-00205-2","author":"G Bitetto","year":"2020","unstructured":"Bitetto G, Fonzo AD. Nucleo\u2013cytoplasmic transport defects and protein aggregates in neurodegeneration. Transl Neurodegen. 2020. https:\/\/doi.org\/10.1186\/s40035-020-00205-2.","journal-title":"Transl Neurodegen"},{"key":"2763_CR21","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1210\/me.2009-0056","volume":"23","author":"HL Storr","year":"2009","unstructured":"Storr HL, Kind B, Parfitt DA, Chapple JP, Lorenz M, Koehler K, et al. Deficiency of ferritin heavy-chain nuclear import in triple A syndrome implies nuclear oxidative damage as the primary disease mechanism. Mol Endocrinol. 2009;23:2086\u201394. https:\/\/doi.org\/10.1210\/me.2009-0056.","journal-title":"Mol Endocrinol"},{"key":"2763_CR22","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1210\/en.2013-1241","volume":"154","author":"R Prasad","year":"2013","unstructured":"Prasad R, Metherell LA, Clark AJ, Storr HL. Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis. Endocrinology. 2013;154:3209\u201318. https:\/\/doi.org\/10.1210\/en.2013-1241.","journal-title":"Endocrinology"},{"key":"2763_CR23","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1073\/pnas.0505598103","volume":"103","author":"M Hirano","year":"2006","unstructured":"Hirano M, Furiya Y, Asai H, Yasui A, Ueno S. ALADINI482S causes selective failure of nuclear protein import and hypersensitivity to oxidative stress in triple A syndrome. Proc Natl Acad Sci. 2006;103:2298\u2013303. https:\/\/doi.org\/10.1073\/pnas.0505598103.","journal-title":"Proc Natl Acad Sci"},{"key":"2763_CR24","doi-asserted-by":"publisher","first-page":"e0124582","DOI":"10.1371\/journal.pone.0124582","volume":"10","author":"R J\u00fchlen","year":"2015","unstructured":"J\u00fchlen R, Idkowiak J, Taylor AE, Kind B, Arlt W, Huebner A, et al. Role of ALADIN in human adrenocortical cells for oxidative stress response and steroidogenesis. PLoS ONE. 2015;10:e0124582. https:\/\/doi.org\/10.1371\/journal.pone.0124582.","journal-title":"PLoS ONE"},{"key":"2763_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddz236","author":"G Bitetto","year":"2019","unstructured":"Bitetto G, Ronchi D, Bonato S, Pittaro A, Compagnoni GM, Bordoni A, et al. Loss of the nucleoporin Aladin in central nervous system and fibroblasts of Allgrove syndrome. Hum Mol Genet. 2019. https:\/\/doi.org\/10.1093\/hmg\/ddz236.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2763_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1530\/EJE-17-0642","volume":"178","author":"F Roucher-Boulez","year":"2018","unstructured":"Roucher-Boulez F, Brac de la Perriere A, Jacquez A, Chau D, Guignat L, Vial C, Morel Y, Nicolino M, Raverot G, Pugeat M. Triple-A syndrome: a wide spectrum of adrenal dysfunction. Eur J Endocrinol. 2018;178(3):199\u2013207. https:\/\/doi.org\/10.1530\/EJE-17-0642.","journal-title":"Eur J Endocrinol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02763-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02763-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02763-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T23:09:52Z","timestamp":1687129792000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02763-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2763"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02763-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2148123\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"assertion":[{"value":"11 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patient. The relevant ethical authorities, \u201cComitato Etico Milano Area 2\u201d, approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}